Cantor Fitzgerald, L. P. Cyteir Therapeutics, Inc. Put Options Transaction History
Cantor Fitzgerald, L. P.
- $1.04 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CYT
# of Institutions
2Shares Held
2.47MCall Options Held
0Put Options Held
0About Cyteir Therapeutics, Inc.
- Ticker CYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,413,400
- Market Cap $107M
- Description
- Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...